Author:
Nisar Memoona,Tasleem Zermina,Muhammad Sohail Ayaz,Javid Asma,Rasool Muhammad Fawad,Karuniawati Hidayah,Al-Tamimi Saleh Karamah,Rehman Anees Ur
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Shah S, Abbas G, Hanif M, Anees-Ur-Rehman, Zaman M, Riaz N, et al. Increased burden of disease and role of health economics. Asia-Pacific Region. 2019;19(5):517–28.
2. Shah S, Abbas G, Riaz N, ur Rehman A, Hanif M, Rasool MFJE, et al. Burd Commun Dis cost Illness: Asia Pac Region. 2020;20(4):343–54.
3. Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. 2012.
4. Liem YS, Bosch JL, Hunink MMJVH. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. 2008;11(4):733–41.
5. Eriksson JK, Neovius M, Jacobson SH, Elinder C-G, Hylander BJB. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden. 2016;6(10):e012062.